Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?

Virganeyce Lyons-Boudreaux1, Dina R Mody, Jim Zhai

  • 1Weill Medical College of Cornell University, The Methodist Hospital, Department of Pathology, Houston, TX 77030, USA.

Abstract